Doctor Challenges AstraZeneca Drug

AstraZeneca's anticlotting drug Brilinta was approved based on a study showing the pill saved lives and reduced heart attacks. But a drama is unfolding over whether the drug should have been approved.



from WSJ.com: US Business http://ift.tt/1fPJEAr

via IFTTT